Características maternas e fatores de risco para pré-eclâmpsia em gestantes
DOI:
https://doi.org/10.15253/2175-6783.20192040327Palavras-chave:
Fatores de Risco; Pré-Eclâmpsia; Cuidado Pré-Natal; Gravidez de Alto Risco.Resumo
Objetivo: investigar as características maternas e os fatores de risco para o desenvolvimento da pré-eclâmpsia em gestantes. Métodos: estudo documental e retrospectivo, conduzido em fichas de cadastro de gestantes de seis equipes da Estratégia Saúde da Família. Foram utilizadas as informações de 94 gestantes, sendo esses dados coletados por meio de um formulário. Resultados: as gestantes possuíam idade entre 15 e 47 anos. Os fatores de risco para o desenvolvimento de pré-eclâmpsia presentes na amostra foram a primiparidade 40 (42,6%), a hipertensão crônica 4 (4,3%), a gravidez múltipla 9 (9,6%), o diabetes mellitus e a obesidade 8 (8,6%) e a idade >40 anos (1,1%). Conclusão: houve a presença de alguns fatores de risco para o desenvolvimento da pré-eclâmpsia nos cadastros avaliados, como primiparidade, hipertensão crônica, diabetes mellitus e obesidade.
Referências
Adeyinka O, Jukic AM, McGarvey ST, Muasau-Howard BT, Faiai M, Hawley. Predictors of prenatal care satisfaction among pregnant women in American Samoa. BMC Pregnancy Childbirth. 2017; 17(1):381. doi: https://doi.org/10.1186/s12884-017-1563-6
Al-rubaie ZTA, Askie LM, Ray JG, Hudson HM, Lord SJ. The performance of risk prediction models for pre-eclampsia using routinely collected maternal characteristics and comparison with models that include specialised tests and with clinical guideline decision rules: a systematic review. Int J Obstetr Gynaecol. 2016; 123:1441-52. doi: https://doi.org/10.1111/1471-0528.14029
Erez O, Romero R, Maymon E, Chaemsaithong P, Done B, Pacora P, et al. The prediction of late-onset preeclampsia: results from a longitudinal proteo- mics study. PLoS One. 2017; 12(7):e0181468. doi: https://doi.org/10.1371/journal.pone.0181468
Ramos JGL, Sass N, Costa SHM. Preeclampsia. Rev Bras Ginecol Obstet. 2017; 39(9):496-12. doi: https://doi.org/10.1055/s-0037-1604471
Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol. 2015; 213(1):62.e1-10. doi: https://doi.org/10.1016/j.ajog.2015.02.018
Cadavid AP. Aspirin: the mechanism of action revisited in the context of pregnancy complications. Front Immunol. 2017; 8:261. doi: https://doi.org/10.3389/fimmu.2017.00261
The American College of Obstetricians and Gynecologists. Committee Opinion No. 638: first-trimester risk assessment for early-onset preeclampsia. Obstet Gynecol. 2015; 126(3):e25-7. doi: https://doi.org/10.1097/AOG.0000000000001049
Malachias MVB, Gomes MAM, Nobre F, Alessi A, Feitosa AD, Coelho EB. 7th Brazilian Guideline of Arterial Hypertension: chapter 2 - diagnosis and classification. Arq Bras Cardiol. 2016; 107(3Supl.3):1-83. doi: http://dx.doi.org/10.5935/abc.20160152
O’Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol. 2016; 214(1):103.e1-e12. doi: https://dx.doi.org/10.1016/j.ajog.2015.08.034
Linhares JJ, Macêdo NMQ, Arruda GM, Vasconcelos JLM, Saraiva TV, Ribeiro AF. Fatores associados à via de parto em mulheres com pré-eclâmpsia. Rev Bras Ginecol Obstet. 2014; 36(6):259-63. doi: https://dx.doi.org/10.1590/S0100-720320140004812
Silva PLN, Oliveira JS, Santos APO, Vaz MDT. Cuidados pré-natais e puerperais às gestantes de um centro de saúde de Minas Gerais quanto ao risco de pré-eclâmpsia: aspectos clínicos, nutricionais e terapêuticos. J Health Biol Sci. 2017; 5(4):346-51. doi: http://dx.doi.org/10.12662/2317-3076jhbs.v5i4.1222.p346-351.2017
Grum T, Seifu A, Abay M, Angesom T, Tsegay L. Determinants of pre-eclampsia/eclampsia among women attending delivery services in selected public hospitals of Addis Ababa, Ethiopia: a case control study. BMC Pregnancy Childbirth. 2017; 7(1):307. doi: https://dx.doi.org/10.1186/s12884-017-1507-1
Guerrier G, Oluyide, B, Keramarou M, Grais, RF. Factors associated with severe preeclampsia and eclampsia in Jahun, Nigeria. Int J Womens Health. 2013; 5:509-13. doi: https://dx.doi.org/10.2147/IJWH.S47056
Monteiro ALS, Soares MC, Maciel PC, Nascimento DJ. Avaliação epidemiológica de gestantes hipertensas crônicas da maternidade HC-UFPR. Rev Med UFPR. 2017; 4(1):17-22. doi: https://dx.doi.org/10.5380/rmu.v1i1
Lima JP, Veras LLN, Pedrosa EKFS, Oliveira GSC, Guedes MVC. Socioeconomic and clinical profile of pregnant women with Gestational Hypertension Syndrome. Rev Rene. 2018; 19:e3455. doi: https://dx.doi.org/10.15253/2175-6783.2018193455
Stubert J, Reister F, Hartmann S, Janni W. The risks associated with obesity in pregnancy. Dtsch Arztebl Int. 2018; 115(16):276-83. doi: https://dx.doi.org/10.3238/arztebl.2018.0276
Schummers L, Hutcheon JA, Bodnar LM, Lieberman E, Himes KP. Risk of adverse pregnancy outcomes by prepregnancy body mass index: a population-based study to inform prepregnancy weight loss counseling. Obstet Gynecol. 2015; 125(1):133-43. doi: https://dx.doi.org/10.1097/AOG.0000000000000591
Roberge S, Odibo AO, Bujold E. Aspirin for the prevention of preeclampsia and intrauterine grow restriction. Clin Lab Med. 2016; 36(2):319-29. doi: https://dx.doi.org/10.1016/j.cll.2016.01.013
Mone F, Mulcahy C, McParland P, McAuliffe FM. Should we recommend universal aspirin for all pregnant women?. Am J Obstet Gynecol. 2017; 216(2):141.e1-e5. doi: https://dx.doi.org/10.1016/j.ajog.2016.09.086
Rocha RS, Alves JAG, Moura SBMH, Araujo Júnior E, Peixoto AB, Santana EFM, et al. Simple approach based on maternal characteristics and mean arterial pressure for the prediction of preeclampsia in the first trimester of pregnancy. J Perinat Med. 2017; 45(7):843-9. doi: https://dx.doi.org/10.1515/jpm-2016-0418
